Iovance Biotherapeutics, Inc. · NASDAQ:IOVA
BlackRock, Inc. reported a 6.40% stake in Iovance Biotherapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Jul 17, 2025
BlackRock, Inc. reported a 6.40% stake in Iovance Biotherapeutics, Inc., 21,305,651 shares, as a passive investor on Jun 30, 2025. Filed Jul 17, 2025 (Schedule 13G/A).
- Stake
- 6.40%
- Shares
- 21,305,651
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 6.40% | 21,305,651 |
Source
Related
- Iovance Biotherapeutics, Inc.
- BlackRock, Inc.
- Iovance Biotherapeutics, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Vogt Frederick G · Sep 10, 2026
- Form 4 · Bilinsky Igor · Sep 10, 2026
- Form 4 · Puri Raj K. · Sep 10, 2026
- Form 4 · Vogt Frederick G · Sep 3, 2026
- Form 4 · Puri Raj K. · Sep 3, 2026